Novolog Overview
About Novolog
Novolog (pharm-up 1966) Ltd is an Israeli public health care company. The company operates in four divisions: The digital division, Health Division, The logistics division and International health services.
Founded
1966
HQ
Employees
N/A
Website
Financials (Last FY)
EV
$132M
Valuation Multiples
Start free trialNovolog Stock Performance
Novolog has current market cap of $141M, and enterprise value of $132M.
Novolog's stock price is $0.28.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $132M | $141M | -0.0% | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNovolog Valuation Multiples
Novolog Financial Valuation Multiples
As of October 19, 2026, Novolog has market cap of $141M and EV of $132M.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Novolog Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Novolog Competitors
Novolog competitors include Orian SH.M., Empa Electronics, DISWAY, Bastide Le Confort Médical, Cheffelo, Ingram Micro Türkiye, Oriola, PBS Group, Ferronordic and Lindbergh.
Most Novolog public comparables operate across Wholesale Distribution and Logistics & Air Freight.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | - | - | |||
| - | - | - | - | - | - | |||
| $215M | $14M | 0.6x | 0.6x | 10.0x | 7.6x | |||
| $552M | $113M | 0.9x | 0.9x | 4.3x | 4.2x | |||
| $120M | $12M | 1.0x | 0.9x | 10.4x | 7.8x | |||
| $549M | $6M | 0.5x | - | 41.0x | - | |||
| $2.1B | ($14M) | 0.1x | 0.2x | (8.2x) | 3.2x | |||
| $375M | $54M | 0.9x | - | 6.4x | - | |||
This data is available for Pro users. Sign up to see all Novolog competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Novolog
| When was Novolog founded? | Novolog was founded in 1966. |
| Where is Novolog headquartered? | Novolog is headquartered in Israel. |
| Is Novolog publicly listed? | Yes, Novolog is a public company listed on Tel Aviv Stock Exchange. |
| What is the stock symbol of Novolog? | Novolog trades under NVLG ticker. |
| When did Novolog go public? | Novolog went public in 2017. |
| Who are competitors of Novolog? | Novolog main competitors include Orian SH.M., Empa Electronics, DISWAY, Bastide Le Confort Médical, Cheffelo, Ingram Micro Türkiye, Oriola, PBS Group, Ferronordic, Lindbergh. |
| What is the current market cap of Novolog? | Novolog's current market cap is $141M. |
| Is Novolog profitable? | No, Novolog is not profitable. |
| How many companies Novolog has acquired to date? | Novolog hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Novolog has invested to date? | Novolog hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Novolog
Lists including Novolog
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




